Luteal Phase Support in IVF: Progesterone Routes, Timing and Duration

After an IVF stimulation cycle, the body's own luteal function is usually not enough to support implantation. Luteal phase support (LPS) is therefore a routine part of every fresh IVF and ICSI cycle, and getting it right is a core skill for any clinician in reproductive medicine.

Key takeaways

• Ovarian stimulation and oocyte retrieval disturb normal corpus luteum function, so progesterone support is recommended after IVF and ICSI.
• Vaginal, intramuscular, subcutaneous and oral (dydrogesterone) progesterone are all used; the choice balances effectiveness, comfort and cost.
• ESHRE guidance advises starting between the evening of oocyte retrieval and day 3, and continuing at least until the pregnancy test.
• hCG is not recommended for routine luteal support because it raises the risk of OHSS.

Why IVF cycles need luteal support

In a natural cycle, the corpus luteum produces progesterone that prepares the endometrium for implantation. In a stimulated IVF cycle, several factors disturb this:

• High oestradiol and progesterone levels from multiple follicles suppress the pituitary's LH output
• GnRH analogues used to prevent an early LH surge further reduce luteal LH support
• Aspiration of the follicles may remove some granulosa cells

The result is a shortened or inadequate luteal phase, which is why progesterone support improves pregnancy outcomes after IVF.

Routes of progesterone

Vaginal progesterone (gel, tablets or pessaries) is the most widely used route. It gives high local levels in the uterus and avoids injections, although some women find discharge or irritation bothersome.

Intramuscular progesterone in oil produces high blood levels but involves painful daily injections and a risk of injection-site reactions.

Subcutaneous progesterone is an alternative injectable form that is easier to self-administer.

Oral dydrogesterone has been compared with vaginal progesterone in large randomised trials and was found to be similarly effective, with the convenience of a tablet.

When to start and how long to continue

ESHRE's ovarian stimulation guideline recommends starting progesterone between the evening of oocyte retrieval and day 3 after retrieval. Support should continue at least until the day of the pregnancy test. Many clinics continue into early pregnancy, but evidence that prolonged support improves outcomes is limited.

What about hCG and GnRH agonist?

hCG can support the corpus luteum, but it is not recommended for routine luteal support because it increases the risk of ovarian hyperstimulation syndrome. In cycles triggered with a GnRH agonist, the luteal phase needs special attention, and clinics follow specific protocols or move to a freeze-all strategy.

Frozen embryo transfer cycles

In artificially prepared (hormone replacement) frozen embryo transfer cycles, there is no corpus luteum, so progesterone is essential, not optional. Timing the start of progesterone correctly relative to the embryo stage is critical.

Counselling patients on luteal support

Patients often worry about missed doses or side effects. Explain the purpose of progesterone, how and when to use it, what to do if a dose is missed and which symptoms need a call to the clinic. Written instructions reduce errors, especially when several medicines start at once after oocyte retrieval.

Frequently asked questions

Is one progesterone route better than the others?

For fresh IVF cycles, vaginal, injectable and oral dydrogesterone routes have shown broadly similar results in trials. The choice usually depends on patient preference, side effects and cost.

Does measuring progesterone levels help?

Serum progesterone monitoring is used in some frozen transfer protocols, but there is no single agreed threshold, and practice varies between clinics.

Can luteal support be stopped at the pregnancy test?

Many studies suggest stopping at a positive pregnancy test does not reduce ongoing pregnancy rates, but practice varies, and clinicians should follow their unit's protocol.

Learn luteal phase management at ReproNest

ReproNest's Fellowship in Reproductive Medicine covers stimulation, trigger choice and luteal phase support through case-based teaching. Read our guide to IVF stimulation protocols, or contact us.

This article is educational content for healthcare professionals and trainees. It is not medical advice and does not replace clinical judgement, current guidelines or the ART (Regulation) Act 2021 and Rules 2022.